A study published by SMG Marketing Group of Chicago shows that the number of U.S. imaging centers profiled by the company increased in the first three quarters of 1999 by 5% compared to the year before, climbing from 2661 to 2801. The imaging center
A study published by SMG Marketing Group of Chicago shows that the number of U.S. imaging centers profiled by the company increased in the first three quarters of 1999 by 5% compared to the year before, climbing from 2661 to 2801. The imaging center market has seen steady expansion since 1989, when there were 1502 sites across the U.S.
SMG reports that firms such as HealthSouth of Birmingham, AL, Medical Resources of Hackensack, NJ, and U.S. Diagnostic of West Palm Beach, FL, dominate this market, and have been changing the imaging center landscape with mergers and acquisitions. In the first three quarters of 1999, U.S. Diagnostic moved from first place in the market to third when it sold its underperforming facilities, decreasing its owned centers from 108 to 69 (SCAN 3/3/99). In the meantime, HealthSouth became the largest imaging center chain in the U.S., with 122 centers, while Medical Resources came in second with 84.
New Collaboration Offers Promise of Automating Prior Authorizations in Radiology with AI
March 26th 2025In addition to a variety of tools to promote radiology workflow efficiencies, the integration of the Gravity AI tools into the PowerServer RIS platform may reduce time-consuming prior authorizations to minutes for completion.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Study Explores Impact of Insurance on Treatment and Referrals for Patients with Uterine Fibroids
February 19th 2025Women with uterine fibroids and Medicaid coverage are significantly more likely to be treated with uterine artery embolization than those with commercial insurance, according to newly published research.